The Minister of Health, César Vásquez, recognized a “significant increase in coronavirus cases” in the country, due to the new JN.1 sublineage, descendant of the Ómicron BA.2.86 variant, but clarified that “we are not facing a sixth wave” of infections.
SEE ALSO: COVID-19: Minsa confirms the presence of the JN.1 variant in Peru
“We are not facing a sixth wave… Although it is true that there was a significant increase in coronavirus cases, the vast majority are patients infected with the new JN.1 sublineage, which is highly contagious, but of low lethality,” Vasquez declared.
He also specified that 13 people have died so far in 2,024 victims of the infection: 11 were over 65 years old and had comorbidities, and two adults had underlying pathologies.
TESTS AND VACCINES
According to the Ministry of Health, Peru reported 6,376 cases of coronavirus between December 26 and January 1, while the accumulated incidence rate was 42.16.
In this scenario, the minister stressed that “the bivalent vaccine protects against severe cases or mortality of coronavirus variants, including the JN.1 sublineage.” However, he admitted that the molecular exclusion tests “are sold out in some places,” so they will be redistributed and a new test purchase will be made.
I KNEW THAT
The Ministry of Health (Minsa) has 241 thousand antigen tests nationwide to meet the demand of the population.
This sector evaluates the future purchase of the updated monovalent vaccine, which protects against the JN.1 sublineage.
Perú21 ePaper, go here and try it for free.
RECOMMENDED VIDEO
Mayor of San Román-Juliaca delivers monument for violent riot in Juliaca (Puno)
2024-01-09 12:00:00
#significant #increase #COVID19 #infections
